We are live on ! Find out more
CL

CRCM LP Portfolio holdings

AUM $141M
1-Year Est. Return 153.09%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+153.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
-$155M
Cap. Flow
-$156M
Cap. Flow %
-110.37%
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
3
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$48.6M
2
AIFC
AI Financial Corp
AIFC
+$2.72M
3
STAA icon
STAAR Surgical
STAA
+$1.91M
4
PLBY icon
Playboy Inc
PLBY
+$1.2M

Sector Composition

Rank Sector Weight
1 Technology 10.06%
2 Consumer Discretionary 4.68%
3 Healthcare 4.58%
4 Financials 2%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAU icon
1
iShares Gold Trust
IAU
$63B
$111M 78.68%
1,249,870
+530,148
+74% +$48.6M
AIFC
2
AI Financial Corp
AIFC
$60.6M
$14M 9.91%
12,611,530
+1,670,250
+15% +$2.72M
PLBY icon
3
Playboy Inc
PLBY
$141M
$6.61M 4.68%
4,345,517
+656,065
+18% +$1.2M
BNR
4
Burning Rock Biotech
BNR
$94.4M
$4.6M 3.26%
282,097
-209,329
-43% -$5.48M
STAA icon
5
STAAR Surgical
STAA
$1.16B
$1.87M 1.32%
+100,000
New +$1.91M
PCAP
6
ProCap Acquisition Corp
PCAP
$327M
$1.55M 1.1%
152,367
-154,152
-50% -$1.57M
PCSC
7
DELISTED
Perceptive Capital Solutions
PCSC
$1.28M 0.9%
116,245
-302,839
-72% -$3.86M
USBC
8
USBC Inc
USBC
$123M
$214K 0.15%
555,325
-2,015,987
-78% -$935K
HHH icon
9
Howard Hughes
HHH
$3.93B
-612,839
Closed -$48.9M
RNAM
10
DELISTED
Avidity Biosciences
RNAM
-202,370
Closed -$14.6M
WBD icon
11
Warner Bros
WBD
$64.6B
-1,500,000
Closed -$43.2M
GRAL
12
GRAIL Inc
GRAL
$2.91B
-1,072,374
Closed -$91.8M

Similar funds

CRCM LP's Q1 2026 Portfolio in Review

As of Q1 2026, CRCM LP held 12 positions worth $141M, down 52% from $296M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

CRCM LP withdrew a net $156M in Q1 2026, closing 4 positions and reducing 4 holdings. Its most notable exit was GRAIL Inc, an estimated $91.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, CRCM LP opened a new position in STAAR Surgical worth $1.87M.

  • CRCM LP's largest Q1 2026 buy was STAAR Surgical: 100,000 shares worth $1.87M.
  • CRCM LP added most to iShares Gold Trust in Q1 2026, an estimated $48.6M increase.
  • CRCM LP's biggest Q1 2026 reduction was Burning Rock Biotech, cutting an estimated $5.48M.
  • CRCM LP fully exited GRAIL Inc in Q1 2026, selling an estimated $91.8M.
  • CRCM LP's ten largest holdings make up 100% of its $141M portfolio in Q1 2026.
  • CRCM LP opened 1 new position and closed 4 in Q1 2026.
  • CRCM LP's portfolio value fell 52% quarter-over-quarter to $141M.

Based on CRCM LP's 13F filing for Q1 2026, filed 13 May 2026.